IL236172B - Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
- Google Patents
Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
Info
Publication number
IL236172B
IL236172BIL236172AIL23617214AIL236172BIL 236172 BIL236172 BIL 236172BIL 236172 AIL236172 AIL 236172AIL 23617214 AIL23617214 AIL 23617214AIL 236172 BIL236172 BIL 236172B
The Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2013/050503external-prioritypatent/WO2013186777A2/en
Application filed by The Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center FundfiledCriticalThe Medical Res Infrastructure And Health Services Fund Of The Tel Aviv Medical Center Fund
Priority to IL236172ApriorityCriticalpatent/IL236172B/en
Publication of IL236172A0publicationCriticalpatent/IL236172A0/en
Publication of IL236172BpublicationCriticalpatent/IL236172B/en
IL236172A2012-06-142014-12-11Use of blocking agents of bone morphogenic protein (bmp) signaling for the treatment of neuroinflammatory and neurodegenerative diseases
IL236172B
(en)
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)